TY - JOUR
KW - Administration, Sublingual
KW - Adolescent
KW - Adolescent Health
KW - Analgesics, Opioid/metabolism
KW - Behavior, Addictive/therapy
KW - Buprenorphine, Naloxone Drug Combination/administration & dosage/adverse effects/therapeutic use
KW - Buprenorphine/administration & dosage/adverse effects/therapeutic use
KW - Dose-Response Relationship, Drug
KW - Drug Overdose/prevention & control
KW - Humans
KW - Narcotic Antagonists/administration & dosage/adverse effects/therapeutic use
KW - Opiate Substitution Treatment/methods
KW - Opioid-Related Disorders/diagnosis/drug therapy/therapy
KW - Patient Care Team
KW - Patient Compliance
KW - Practice Guidelines as Topic
KW - Receptors, Opioid, mu/metabolism
KW - Substance Abuse Detection
AU - C. B. Cottrill
AU - S. C. Matson
A1 - 
BT - Adolescent medicine: state of the art reviews
C5 - Opioids & Substance Use
CP - 2
CY - United States
IS - 2
JF - Adolescent medicine: state of the art reviews
PP - United States
PY - 2014
SN - 1934-4287; 1934-4287
SP - 251
EP - 265
EP - 
T1 - Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults
T2 - Adolescent medicine: state of the art reviews
TI - Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults
U1 - Opioids & Substance Use
U2 - 27132312
VL - 25
VO - 1934-4287; 1934-4287
Y1 - 2014
ER -